Formation of bicalutamide nanodispersion for dissolution rate enhancement

International Journal of Pharmaceutics

Volumn 404, Issue 1-2, 2011, Pages 257-263

  Li, Chan ^a   Li, Caixia ^a   Le, Yuan ^a   Chen, Jian Feng ^a  

^a BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

Author keywords

Bicalutamide; Hydrophilic excipients; In vitro dissolution; Nanodispersion

Indexed keywords

BICALUTAMIDE;

ARTICLE; CHEMICAL STRUCTURE; CONTACT ANGLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; INFRARED SPECTROSCOPY; PARTICLE SIZE; PRIORITY JOURNAL; X RAY DIFFRACTION;

ANDROGEN ANTAGONISTS; ANILIDES; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMICAL PRECIPITATION; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; DRUG COMPOUNDING; EXCIPIENTS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; KINETICS; LACTOSE; NANOPARTICLES; NANOTECHNOLOGY; NITRILES; PARTICLE SIZE; SOLUBILITY; SOLVENTS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE; TOSYL COMPOUNDS; WETTABILITY;

EID: 78650677483     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.11.015     Document Type: Article

References (59)

1. G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison A theoretical basis for biopharmaceutical drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability Pharm. Res. 12 1995 413 420
2. M.E. Brewster, and T. Loftsson Cyclodextrins as pharmaceutical solubilizers Adv. Drug Delivery Rev. 59 2007 645 666
3. R.L. Carrier, L.A. Miller, and I. Ahmed The utility of cyclodextrins for enhancing oral bioavailability Contr. Rel. 123 2007 78 99
4. M.B. Chougule, B.K. Padhi, K.A. Jinturkar, and A. Misra Development of dry powder inhalers Recent Pat Drug Delivery Formul. 1 2007 11 21
5. K.J. Crowley, and G. Zografi Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formation and amorphous phase physical stability Pharm. Sci. 91 2 2002 492 507
6. M.E. Davis, and M.E. Brewster Cyclodextrin based pharmaceutics: past, present and future Nat. Rev. Drug Discov. 3 2004 1025 1035
7. M.M. De Villiers Influence of agglomeration of cohesive particles on the dissolution behaviour of furosemide powder Int. J. Pharm. 136 1996 175 179
8. J.C. Dinunzio, D.A. Miller, W. Yang, G.W. Mcginity, and R.O. Williams Amorphous compositions using concentration enhancing polymers for improved bioavailability of itraconazole Mol. Pharm. 5 6 2008 968 980
9. N. EI-Gendy, and C. Berkland Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration Pharm. Res. 26 7 2009 1752 1763
10. A. Fini, C. Cavallari, and F. Ospitali Raman and thermal analysis of indomethacin/PVP solid dispersion evteric microparticles Eur. J. Pharm. Biopharm. 70 2008 409 420
11. I. Kanfer Report on the international workshop on the biopharmaceutics classification system (BCS): scientific and regulatory aspects in practice J. Pharm. Sci. 5 2000 1 4
12. M. Karjalainen, S. Airaksinen, J. Rantanen, J. Aaltonen, and J. Yliruusi Characterization of polymorphic solid-state changes using variable temperature X-ray powder diffraction Pharm. Biomed. 39 1-2 2005 27 32
13. C.M. Keck, A.H. Hommoss, and R.H. Mueller Lipid nanoparticles for encapsulation of actives: dermal and oral formulations Am. Pharm. Rev. 10 2007 78 82
14. M. Kennedy, J. Hu, P. Gao, L. Li, A. Ali-Reynolds, B. Chal, V. Gupta, C. Ma, N. Mahajan, A. Akrami, and S. Surapaneni Enhanced bioavailability of a poorly soluble VR1 antagonist using n amorphous solid dispersion approach: a case study Mol. Pharm. 5 6 2008 981 993
15. F. Kesisoglou, S. Panmai, and Y. Wu Application of nanoparticles in oral delivery of immediate release formulations Curr. Nanosci. 3 2007 183 190
16. J.P. Lakshman, Y. Cao, J. Kowalski, and A.T.M. Serajuddin Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug Mol. Pharm. 5 6 2008 994 1002
17. Y. Le, H. Ji, J.F. Chen, Z.G. Shen, J. Yun, and M. Pu Nanosized bicalutamide and its molecular structure in solvents Int. J. Pharm. 370 2009 175 180
18. L. Lindfors, S. Forssen, P. Skantze, U. Skantze, A. Zackrisson, and U. Olsson Amorphous drug nanosuspensions. 2. Experimental determination of bulk monomer concentrations Langmuir 22 2006 911 916
19. C.A. Lipinski Avoiding investment in doomed drugs Curr. Drug Discov. 2001 17 19
20. C.A. Lipinski Poor aqueous solubility-an industry wide problem in drug discovery Am. Pharm. Rev. 5 2002 82 85
21. 13C NMR study of indomethacin polymorphism Int. J. Pharm. 318 1-2 2006 146 153
22. M.E. Matteucci, M.A. Hotze, K.P. Johnston, and R.O. Williams III Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization Langmuir 22 21 2006 8951 8959
23. C. Medina, M.J. Santos-Martinez, A. Radomski, O.I. Corrigan, and M.W. Radomski Nanoparticles: pharmacological and toxicological significance Br. J. Pharmacol. 150 2007 552 558
24. E.M. Merskio-Liversidge, and G.G. Liversidge Drug nanoparticles: formulating poorly water soluble compounds Toxicol. Pathol. 36 2008 43 48
25. T.H. Muster, and C. Prestidge Face specific surface properties of pharmaceutical crystals J. Pharm. Sci. 91 6 2002 1432 1444
26. A. Newman, D. Engers, S. Bates, I. Ivanisevic, R.C. Kelly, and G. Zografi Characterization of amorphous API: polymer mixtures using X-ray powder diffraction J. Pharm. Sci. 97 11 2008 4840 4856
27. X. Pan, T. Julian, and L. Augsburger Increasing the dissolution rate of a low-solubility drug through a crystalline-amorphous transition: a case study with indomethicin Drug Dev. Ind. Pharm. 34 2 2008 221 231
28. D.L. Pole Physical and biological considerations for the use of nonaqueous solvents in oral bioavailability enhancement Pharm. Sci. 97 2008 1071 1088
29. C.J. Porter, N. Trevaskis, and W.N. Charman Lipids and lipid-Based formulations: optimizing the oral delivery of lipophilic drugs Nat. Rev. Drug Discov. 6 3 2007 231 248
30. C.J. Porter, K.J. Wasan, and P. Constantinides Lipid-based systems for enhanced delivery of poorly water soluble drugs Adv. Drug Delivery Rev. 59 2008 615 778
31. N.P. Praetorius, and T.K. Mandal Engineered nanoparticles in cancer therapy Recent Pat. Drug Delivery Formul. 1 2007 37 51
32. B.E. Rabinow Nanosuspensions in drug delivery Nat. Rev. Drug Discov. 3 2004 785 796
33. T.L. Rogers, I.B. Gillespie, J.E. Hitt, K.L. Fransen, C.A. Crowl, C.J. Tucker, G.B. Kupperblatt, J.N. Becker, D.L. Wilson, C. Todd, C.F. Broomall, J.C. Evans, and E.J. Elder Development and characterization of a scalable controlled precipitation process to enhance the dissolution of poor water-soluble drugs Pharm. Res. 21 2004 2048 2057
34. G.P. Sanganwar, and R.M. Gupta Enhancement of shelf life and handling properties of drug nanoparticles: nanoscale mixing of itraconazole with silica Ind. Eng. Chem. Res. 47 2008 4717 4725
35. M. Sarkari, J. Brown, X. Chen, S. Swinnea, R.O. Williams, and K.P. Johnston Enhanced drug dissolution using evaporative precipitation into aqueous solution Int. J. Pharm. 243 2002 17 31
36. A.G. Schmidt, S. Wartewig, and K.M. Picker Potential of carrageenans to protect drugs from polymorphic transformation Eur. J. Pharm. Biopharm. 56 1 2003 101 110
37. S. Sepassi, D.J. Goodwin, A.F. Drake, S. Holland, G. Leonard, L. Martini, and M.J. Lawrence Effect of polymer molecular weight on the production of drug nanoparticles J. Pharm. Sci. 96 2007 2655 2666
38. B.Y. Shekunov, P. Chattopadhyay, J. Seitzinger, and R. Huff Nanoparticles of poorly water-soluble drugs prepared by supercritical fluid extraction of emulsions Pharm. Res. 23 2006 196 204
39. S. Simovic, P. Heark, H. Hui, Y. Song, F. Peddie, A.K. Davey, A. Lewis, T. Rades, and C.A. Prestidge Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs Mol. Pharm. 6 3 2009 861 872
40. C.J. Strachan, T. Rades, D.A. Newnham, K.C. Gordon, M. Pepper, and P.F. Taday Using terahertz pulsed spectroscopy to study crystallinity of pharmaceutical materials Chem. Phys. Lett. 390 1-3 2004 20 24
41. E. Swanepoel, W. Liebenberg, M.M. De Villiers, and T.G. Dekker Dissolution properties of proxicam powders and capsules as a function of particle size and the agglomeration of powders Drug Dev. Ind. Pharm. 26 10 2000 1067 1076
42. J.M. Tam, J.T. McConville, R.O. Williams 3rd, and K.P. Johnston Amorphous cyclosporin nanodispersions for enhanced pulmonary deposition and dissolution J. Pharm. Sci. 97 2008 4915 4933
43. M.D. Ticehurst, P.A. Basford, C.I. Dallman, T.M. Lukas, P.V. Marshall, G. Nichols, and D. Smith Characterisation of the influence of micronization on the crystallinity and physical stability of revatropate hydrobromide Int. J. Pharm. 193 2000 247 259
44. G. Torrado, S. Fraile, S. Torrado, and S. Torrado Process-induced crystallite size and dissolution changes elucidated by a variety of analytical methods Int. J. Pharm. 166 1998 55 60
45. A. Tran, S. Simovic, A.K. Davey, T. Rades, and C.A. Prestidge Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs Contr. Rel. 134 1 2009 62 70
46. P.H.L. Tran, H.T.T. Tran, and B.-J. Lee Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release Contr. Rel. 129 1 2008 59 65
47. D.R. Vega, G. Polla, A. Martinez, E. Mendioroz, and M. Reinoso Conformational polymorphism in bicalutamideb Int. J. Pharm. 328 2007 112 118
48. S.R. Vippagunta, and H.G. Brittain Crystalline solids Adv. Drug Deliv. Rev. 48 2001 3 26
49. F. Wang, H. Hui, T.J. Barnes, C. Barnett, and C.A. Prestidge Oxidized mesoporous silicon microparticles for improved oral delivery of poorly soluble drugs Mol. Pharm. 7 1 2010 227 236
50. Z. Wang, J.F. Chen, Y. Le, and Z.G. Shen Preparation of ultrafine beclomethasone dipropionate drug powder by antisolvent precipitation Ind. Eng Chem. Res. 46 2007 4839 4845
51. Z.Y. Yang, Y. Le, T.T. Hu, Z.G. Shen, J.F. Chen, and J. Yun Production of ultrafine sumatriptan succinate particles for pulmonary delivery Pharm. Res. 25 2008 2010 2017
52. P.M. Young, H.K. Chan, H. Chiou, S. Edge, T.H. Tee, and D. Traini The influence of mechanical processing of dry powder inhaler carriers on drug aerosolization performance J. Pharm. Sci. 96 2007 1331 1341
53. T.J. Young, S.M. Mawson, K.P. Johnston, I.B. Henriksen, G.W. Pace, and A.K. Mishra Rapid expansion from supercritical to aqueous solution to produce submicron suspensions of water-insoluble drugs Biotechnol. Prog. 16 2000 402 407
54. P. Zahedi, and P.I. Lee Solid molecular dispersions of poorly watersoluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels Eur. J. Pharm. Biopharm. 65 3 2007 320 328
55. H.F. Zhang, D. Wang, R. Butler, N.L. Campbell, J. Long, B. Tan, D.J. Duncalf, A.J. Foster, A. Hopkinson, D. Taylor, D. Angus, A.I. Cooper, and S.P. Rannard Formation and enhanced biocidal activity of water-dispersable organic nanoparticles Nat. Nanotechnol. 3 2008 506 511
56. J.Y. Zhang, and Z.G. Shen Preparation of amorphous cefuroxime axetil nanoparticles by controlled nanoprecipitation method without surfactants Int. J. Pharm. 323 2006 153 160
57. Z. Zhang, and S.S. Feng Nanoparticles of poly(lactide)/vitamin ETPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release Biomaterials 27 2006 262 270
58. H. Zhao, Y. Le, H.Y. Liu, T.T. Hu, Z.G. Shen, J. Yun, and J.F. Chen Preparation of microsized spherical aggregates of ultrafine ciprofloxacin particles for dry powder inhalation (DPI) Powder Technol. 194 2009 81 86
59. L. Zhu, L. Wong, and L. Yu Surface-enhanced crystallization of amorphous nifedipine Mol. Pharm. 5 6 2008 921 926